This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliografia
Holloway RG (1996) Cost-effectiveness analysis: what is it and how will it influence neurology. Ann Neurol 39(6): 818–823
Newby D, Hill S (2003) Use of pharmacoeconomics in prescribing research. Part 2: cost-minimization analysis—when are two therapies equal? J Clin Pharm Ther 28(2):145–150
Lopert R, Lang DL, Hill SR (2003) Use of pharmacoeconomics in prescribing research. Part 3: Cost-effectiveness analysis—a technique for decision-making at the margin. J Clin Pharm Ther 28(3):243–249
Brinsmead R, Hill S (2003) Use of pharmacoeconomics in prescribing research. Part 4: is cost-utility analysis a useful tool? J Clin Pharm Ther 28(4):339–346
EuroQol Group (1990) EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16:199–208
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483
Lang DL, Lopert R, Hill SR (2003) Use of pharmacoeconomics in prescribing research. Part 5: modelling — beyond clinical trials. J Clin Pharm Ther 28(5):433–439
Rights and permissions
Copyright information
© 2005 Springer-Verlag Italia
About this chapter
Cite this chapter
Portaccio, E., Amato, M. (2005). Studi farmacoeconomici: aspetti metodologici. In: Costi sociali e aspetti farmacoeconomici. Aspetti psico-sociali della sclerosi multipla, vol 4. Springer, Milano. https://doi.org/10.1007/88-470-0401-2_5
Download citation
DOI: https://doi.org/10.1007/88-470-0401-2_5
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0327-9
Online ISBN: 978-88-470-0401-6
eBook Packages: MedicineMedicine (R0)